Most Potent Obesity Drug Yet
5:22–6:12 · 50s
Matthew Herper weighs whether the triple-agonist retatrutide truly lives up to the hype and explains why GLP-1 drugs could reshape global health.
5:22–6:12 · 50s
Matthew Herper weighs whether the triple-agonist retatrutide truly lives up to the hype and explains why GLP-1 drugs could reshape global health.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.